Steroidal spiro-gamma-lactones that inhibit 17 beta-hydroxysteroid dehydrogenase activity in human placental microsomes.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1995-10-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00022A018PMID 7473580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3

  1994cited by this paper
• N-butyl, N-methyl, 11-[3',17' beta-(dihydroxy)-1',3',5'(10')-estratrien-16' alpha-yl]-9(R/S)-bromo undecanamide: synthesis and 17 beta-HSD inhibiting, estrogenic and antiestrogenic activities.

  1994cited by this paper
• 1H and 13C nuclear magnetic resonance assignments and stereochemistry of N-n-butyl-N-methyl-11-(16'alpha-chloro-3',17'beta- and 17'alpha-dihydroxyestra-1',3',5'(10')-trien-7'alpha-yl) undecanamide.

  1994cited by this paper
• Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity.

  1993cited by this paper
• Synthesis of new 11 beta-substituted spirolactone derivatives. Relationship with affinity for mineralocorticoid and glucocorticoid receptors.

  1993cited by this paper
• Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues.

  1992cited by this paper
• Subunit identity of the dimeric 17 beta-hydroxysteroid dehydrogenase from human placenta.

  1992cited by this paper
• Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.

  1992cited by this paper
• Multiple steroid metabolic pathways in ZR-75-1 human breast cancer cells.

  1991cited by this paper
• Intracrinology.

  1991cited by this paper
• Stimulation of Androgen‐Dependent Gene Expression by the Adrenal Precursors Dehydroepiandrosterone and Androstenedione in the Rat Ventral Prostate

  1990cited by this paper
• 125I-ligand for progesterone receptor: 17 alpha-(6'-iodohex-1'-ynyl)-19-nortestosterone.

  1989cited by this paper
• Extensive esterification of adrenal C19-delta 5-sex steroids to long-chain fatty acids in the ZR-75-1 human breast cancer cell line.

  1989cited by this paper
• Complete amino acid sequence of human placental 17β‐hydroxysteroid dehydrogenase deduced from cDNA

  1988cited by this paper
• A progesterone receptor affinity chromatography reagent: 17 alpha-hexynyl nortestosterone sepharose.

  1987cited by this paper
• Testicular 17 beta-hydroxysteroid dehydrogenase: molecular properties and reaction mechanism.

  1986cited by this paper
• 17 beta-hydroxysteroid and 20 alpha-hydroxysteroid dehydrogenase activities of human placental microsomes: kinetic evidence for two enzymes differing in substrate specificity.

  1985cited by this paper
• Human ovarian 17 beta-hydroxysteroid oxidoreductase activity: a comparison of normal and polycystic ovarian tissues.

  1983cited by this paper
• Interconversion of estrone and estradiol-17 beta in lung slices of the adult human.

  1982cited by this paper
• [Microsome-associated 17beta-hydroxysteroid dehydrogenases of human placenta, ii kinetic studies and characterization of the solubilized estradiol-and testosterone-"sensitive" 17beta-HSD-Activities].

  1975cited by this paper
• The in vitro and in vivo uptake and metabolism of steroids in human adipose tissue.

  1974cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Quantitative studies on the uptake and metabolism of estrogens and progesterone by human endometrium.

  1972cited by this paper
• 17-beta-hydroxysteroid dehydrogenase from human red blood cells.

  1968cited by this paper
• [Characterization and kinetics of a microsomal 17-beta-hydroxysteroid oxidoreductase from human placenta].

  1967cited by this paper
• Metabolism of oestrone and oestradiol-17-beta in human liver in vitro.

  1966cited by this paper
• Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

  1962cited by this paper

• Benzophenothiazine/Boronic Acid Cooperative Photocatalysis Enables the Synthesis of γ-Lactones via the [3 + 2] Cycloaddition of α,β-Unsaturated Carboxylic Acids with Olefins

  2025cites this paper
• Inhibitors of Brassinosteroid Biosynthesis and Signal Transduction

  2019cites this paper
• Strategic Approach to the Metamorphosis of γ-Lactones to NH γ-Lactams via Reductive Cleavage and C-H Amidation.

  2019cites this paper
• Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges.

  2019cites this paper
• A Passerini/Michael Pathway towards Butyrolactones

  2018cites this paper
• Treatment of estrogen-dependent diseases: Design, synthesis and profiling of a selective 17β-HSD1 inhibitor with sub-nanomolar IC50 for a proof-of-principle study.

  2017cites this paper
• Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis.

  2015cites this paper
• 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting Both the Human Enzyme and Its Murine Ortholog

  2015cites this paper
• Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme.

  2015cites this paper
• Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors.

  2014cites this paper
• Inhibition of 17β-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of new potent inhibitors with thioether linker.

  2014cites this paper
• Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis.

  2013cites this paper
• Novel N-methylsulfonamide and retro-N-methylsulfonamide derivatives as 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors with good ADME-related physicochemical parameters.

  2013cites this paper
• A facile total synthesis of drospirenone isomers containing 14β-hydrogen configuration.

  2013cites this paper
• The role of the endoplasmic reticulum in the metabolism of "xenobiotica"

  2013cites this paper
• Lead optimization of 17β-HSD1 inhibitors of the (hydroxyphenyl)naphthol sulfonamide type for the treatment of endometriosis.

  2012cites this paper
• Efficient synthesis of γ-lactones via gold-catalyzed tandem cycloisomerization/oxidation.

  2012cites this paper
• Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors for the treatment of osteoporosis.

  2012cites this paper
• Synthesis and Biological Evaluation of Spiro-δ-lactones as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2)

  2011cites this paper
• New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases.

  2011cites this paper
• Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.

  2011cites this paper
• Introduction of an electron withdrawing group on the hydroxyphenylnaphthol scaffold improves the potency of 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors.

  2011cites this paper
• Triazole ring-opening leads to the discovery of potent nonsteroidal 17β-hydroxysteroid dehydrogenase type 2 inhibitors.

  2011cites this paper
• Development of potent and selective inhibitors of 17β-hydroxysteroid dehydrogenase type 2 : a new target for the treatment of osteoporosis

  2011cites this paper
• Chemical synthesis of the 17-propanamide derivatives of stereoisomeric Δ14-17α- and 17β-estradiols: potential 17β-hydroxysteroid dehydrogenase inhibitors.

  2011cites this paper
• A powerful combination of computational methods on the road toward potent non-steroidal inhibitors of steroidogenic enzymes involved in hormone-dependent diseases

  2010cites this paper
• Synthesis of 17 alpha-substituted ethynylestradiols: potential ligands for drug vectors.

  2010cites this paper
• New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitory activity and selectivity.

  2009cites this paper
• Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.

  2009cites this paper
• Estradiol dimers as a new class of steroid sulfatase reversible inhibitors.

  2009cites this paper
• Structure-activity study in the class of 6-(3'-hydroxyphenyl)naphthalenes leading to an optimization of a pharmacophore model for 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors.

  2009cites this paper
• Isolation and Structural Elucidation of Related Impurities in Canrenone

  2009cites this paper
• Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.

  2008cites this paper
• Chemical Synthesis of (S)‐Spiro(estradiol‐17,2′‐[1,4]oxazinan)‐6′‐one Derivatives Bearing Two Levels of Molecular Diversity

  2008cites this paper
• Design, synthesis, biological evaluation and pharmacokinetics of bis(hydroxyphenyl) substituted azoles, thiophenes, benzenes, and aza-benzenes as potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1).

  2008cites this paper
• Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.

  2008cites this paper
• Development of a new class of potent and selective non-steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 : bis(hydroxyphenyl)substituted azoles, thiophenes, benzenes and aza-benzenes

  2008cites this paper
• 1,3-Dithioles

  2008cites this paper
• Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1): design, synthesis, biological evaluation, and pharmacokinetics.

  2008cites this paper
• SYNTHESIS OF MODIFIED STEROIDS IN THE ANDROSTANE AND ANDROSTENE SERIES

  2006cites this paper
• Aging Reduces the Efficacy of Estrogen Substitution to Attenuate Cardiac Hypertrophy in Female Spontaneously Hypertensive Rats

  2006cites this paper
• Isolation and identification of novel impurities in spironolactone.

  2006cites this paper
• First synthesis of a steroid containing an unstable 19-nor-androsta-1,5-dien-3-one system

  2006cites this paper
• Lactones: generic inhibitors of enzymes?

  2005cites this paper
• A mammalian steroid action inhibitor spironolactone retards plant growth by inhibition of brassinosteroid action and induces light-induced gene expression in the dark.

  2004cites this paper
• Inhibition of type 2 17β-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure–activity relationships

  2004cites this paper
• Inhibitors of 17 beta-hydroxysteroid dehydrogenases.

  2003cites this paper
• Cutaneous androgen metabolism: basic research and clinical perspectives.

  2002cites this paper
• Inhibitors of type II 17beta-hydroxysteroid dehydrogenase.

  2001cites this paper
• Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers

  2001cites this paper
• Inhibitors of type II 17β-hydroxysteroid dehydrogenase

  2001cites this paper
• N-Butyl-N-methyl-11-(3'-hydroxy-21',17'-carbolactone-19'-nor-17'α-pregna-1',3',5'(10')-trien-7'α-yl)-undecanamide: an inhibitor of type 2 17β-hydroxysteroid dehydrogenase that does not have oestrogenic or androgenic activity

  2000cites this paper
• Androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase.

  2000cites this paper
• Androsterone 3β-substituted derivatives as inhibitors of type 3 17β-hydroxysteroid dehydrogenase

  2000cites this paper
• N-Butyl-N-methyl-11-(3'-hydroxy-21', 17'-carbolactone-19'-nor-17'alpha-pregna-1',3', 5'(10')-trien-7'alpha-yl)-undecanamide: an inhibitor of type 2 17beta-hydroxysteroid dehydrogenase that does not have oestrogenic or androgenic activity.

  2000cites this paper
• Solid-phase synthesis of hydroxysteroid derivatives using the diethylsilyloxy linker.

  2000cites this paper
• Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities.

  1999cites this paper
• 17α-Alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity

  1999cites this paper
• Two non-reactive ternary complexes of estrogenic 17beta-hydroxysteroid dehydrogenase: crystallization and preliminary structural analysis.

  1999cites this paper
• D-ring allyl derivatives of 17β- and 17α-estradiols : Chemical synthesis and 13C NMR data

  1997cites this paper
• D-ring allyl derivatives of 17 beta- and 17 alpha-estradiols: chemical synthesis and 13C NMR data.

  1997cites this paper
• Intracellular regulation of 17 beta-hydroxysteroid dehydrogenase type 2 catalytic activity in A431 cells.

  1997cites this paper
• Steroids: reactions and partial synthesis.

  1997cites this paper
• Steroid-hindered 17 beta-tertiary alcohol: characterization of dehydrated compounds.

  1996cites this paper
• Palladium(II)-catalyzed formation of γ-butyrolactones from 4-trimethylsilyl-3-alkyn-1-ols: Synthetic and mechanistic aspects

  1996cites this paper
• Steroidal Spiro‐γ‐lactones That Inhibit 17β‐Hydroxysteroid Dehydrogenase Activity in Human Placental Microsomes.

  1996cites this paper
• Steroid-hindered 17β-tertiary alcohol: Characterization of dehydrated compounds

  1996cites this paper
• Medicinal Chemistry Research Synthesis, Anti-17β-hsd and Antiproliferative Activity of New Substituted 5-nitrosopyrimidine Analogs

  year unknowncites this paper